These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 393515)

  • 1. Combined effects of BCG or Candida albicans (CA) with antitumor agents against a virus-induced lymphoma in mice.
    Bistoni F; Marconi P; Pitzurra M; Frati L; Spreafico F; Goldin A; Bonmassar E
    Eur J Cancer (1965); 1979 Nov; 15(11):1305-14. PubMed ID: 393515
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular mechanisms underlying the adjuvant activity of Candida albicans in a mouse lymphoma model.
    Marconi P; Cassone A; Tissi L; Baccarini M; Puccetti P; Garaci E; Bonmassar E; Bistoni F
    Int J Cancer; 1982 Apr; 29(4):483-8. PubMed ID: 7044994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of BCG as immunoadjuvant in combination with antitumor drugs in a virus induced leukemia. II].
    Perito S; Cenci E; Sbaraglia G; Vecchiarelli A
    Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2511-7. PubMed ID: 7470294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of BCG as an immunoadjuvant in combination with antitumor agents in virus-induced leukemia].
    Sbaraglia G; Cenci E; Vecchiarelli A; Perito S
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1969-75. PubMed ID: 7459108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Further study of immunopotentiation in experimental antiblastic therapy by inactivated yeasts and glucan].
    Delfina Pesce C; Boccanera M; Marconi P; Bistoni F; Cenci E; Tissi L; Cassone A
    Ann Ist Super Sanita; 1982; 18(3):509-12. PubMed ID: 7187836
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined drug and immunostimulation therapy against a syngeneic murine leukemia.
    Pearson JW; Chirigos MA; Chaparas SD; Sher NA
    J Natl Cancer Inst; 1974 Feb; 52(2):463-8. PubMed ID: 4593139
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immune response to a histocompatible murine lymphoma. Synergism with chemotherapy].
    Scaringi L; Tissi L; Cassone A; Boccanera M; Marconi P
    G Ital Chemioter; 1984; 31(1-2):81-90. PubMed ID: 6381210
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunostimulation with inactivated Candida albicans and chemotherapy in murine lymphoma].
    Tissi L; Scaringi L; Cassone A; D'Errico P; Marconi P
    G Ital Chemioter; 1984; 31(1-2):91-100. PubMed ID: 6381211
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of three strains of BCG against a murine leukemia after drug therapy.
    Sher NA; Pearson JW; Chaparas SD; Chirigos MA
    J Natl Cancer Inst; 1973 Dec; 51(6):2001-3. PubMed ID: 4587756
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunopotentiation of anticancer chemotherapy by Candida albicans, other yeasts and insoluble glucan in an experimental lymphoma model.
    Cassone A; Bistoni F; Cenci E; Pesce CD; Tissi L; Marconi P
    Sabouraudia; 1982 Jun; 20(2):115-25. PubMed ID: 7051368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of chemotherapy and host antitumor response in a murine histocompatible lymphoma model.
    Marconi P; Scaringi L; Tissi L; Puccetti P; Cassone A
    Int J Immunopharmacol; 1984; 6(3):217-22. PubMed ID: 6378809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dose and route of Bacillus Calmette-Guérin in chemoimmunostimulation therapy of a murine leukemia.
    Pearson JW; Chaparas SD; Chirigos MA
    Cancer Res; 1973 Aug; 33(8):1845-8. PubMed ID: 4720796
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the peritoneal cavity in successful treatment of a murine lymphoma with chemotherapy and non-specific immunostimulation.
    Marconi P; Bistoni F; Cassone A; Frati L; Baccarini M; Garaci E; Bonmassar E
    Cancer Immunol Immunother; 1982; 13(2):128-33. PubMed ID: 6760959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunomodulation by inactivated Candida albicans].
    Bistoni F; Marconi P; Cassone A; Frati L
    G Ital Chemioter; 1985; 32(1):147-52. PubMed ID: 3913614
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined chemoimmunostimulation therapy against murine leukemia.
    Pearson JW; Pearson GR; Gibson WT; Chermann JC; Chirigos MA
    Cancer Res; 1972 May; 32(5):904-7. PubMed ID: 4552917
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of malignant melanoma.
    Benjamin RS
    World J Surg; 1979 Jul; 3(3):321-8. PubMed ID: 382646
    [No Abstract]   [Full Text] [Related]  

  • 17. Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.
    Chirigos MA; Pearson JW; Pryor J
    Cancer Res; 1973 Nov; 33(11):2615-8. PubMed ID: 4795224
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolongation of chemotherapeutically induced remission of a syneneic murine leukemia by L-2,3,5,6-tetrahydro-6-phenylimidazo[2.1-BETA]thiazole hydrochloride.
    Chirigos MA; Fuhrman F; Pryor J
    Cancer Res; 1975 Apr; 35(4):927-31. PubMed ID: 1116150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among tumor load, route of tumor inoculation, and response to immunochemotherapy in a murine lymphoma model.
    Marconi P; Cassone A; Baccarini M; Tissi L; Garaci E; Bonmassar E; Frati L; Bistoni F
    J Natl Cancer Inst; 1983 Aug; 71(2):299-307. PubMed ID: 6348362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of immune modulators on the oncogenic process: adjuvant effect of Staphylococcus aureus in treating murine leukemia.
    Chirigos MA; Theodore T
    Ann N Y Acad Sci; 1976; 276():513-9. PubMed ID: 1071976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.